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Abstract
Cutaneous leishmaniasis and Chagas disease (American trypanosomiasis) are two vectorborne, protozoal zoonoses whose emergence into the southern United States is a public health
problem of increasing significance. Cutaneous leishmaniasis is caused by several species of
intracellular protozoa in the genus Leishmania and is most often characterized by the formation
of large, ulcerative skin lesions that can result in considerable scarring and permanent
disfigurement. Infection with Leishmania is prevalent throughout the world in tropical and subtropical regions and in areas where people are regularly exposed to the hematophagous sand fly
vectors that transmit the disease. Chronic infection with Trypanosoma cruzi, the causative agent
of Chagas disease, is a well-known cause of heart failure, arrhythmia, and enlargement of the
esophagus and colon. Between 6 and 8 million people currently living in Latin America and the
United States are believed to be chronically infected with Trypanosoma cruzi with complications
from these infections resulting in approximately 45,000 deaths annually. In the southern United
States, enzootic transmission of both Leishmania mexicana and Trypanosoma cruzi has been
documented in addition to sporadic reports of autochthonous human cases of cutaneous
leishmaniasis and Chagas disease. Future climate change may lead to the emergence of these
pathogens into new foci across the southern United States and could possibly result in an
increase in the incidence of human infections.
Domestic dogs (Canis familiaris) have been implicated as potential reservoirs or
incidental hosts of both Leishmania and Trypanosoma cruzi in endemic foci throughout the
Americas. This study among a sample of stray canines provides evidence that transmission of
these pathogens is occurring in El Paso County, Texas. From July 2014 to May 2015, skin,
spleen, and heart biopsies from 159 stray canines were collected. Genomic DNA of sufficient
quality for use in PCR analyses was successfully extracted from these biopsies in 156 of the stray
canines surveyed. PCR-amplification of Leishmania spp. or Trypanosoma cruzi DNA was
attempted using extracted genomic DNA from these biopsies to screen for evidence of infection.
v

Using agarose gel electrophoresis, Leishmania spp. DNA was detected in 41 stray dogs and
Trypanosoma cruzi DNA was detected in 21 stray dogs, representing 26.3% and 13.5% of the
total sample, respectively. From the group of animals identified as PCR-positive for Leishmania
spp., 18 biopsy PCR products were randomly chosen for bidirectional sequencing. Analysis of
sequenced PCR products showed that all infections were caused by Leishmania mexicana. A
multiple sequence alignment was created to show homology between sequenced PCR products
and known reference strains of Leishmania mexicana and a distantly related species, Leishmania
major.
Collectively, these results suggest that enzootic transmission of Leishmania mexicana
and Trypanosoma cruzi is occurring over a wide portion of El Paso County and nearby densely
populated areas in the city of El Paso. The majority of stray dogs infected with Leishmania
mexicana were found during the late summer and early fall, and the majority of those infected
with Trypanosoma cruzi were found during the late fall and winter, suggesting that these may be
periods during which increased transmission is occurring. The behaviors of many stray canines
and their relatively close associations with humans could potentially put people in El Paso
County at greater risk for infection. Whether the finding of Leishmania mexicana and
Trypanosoma cruzi in these stray canines is evidence of a relatively new emergence of these
pathogens warrants additional investigation. Further research is also needed to better understand
the epidemiology and transmission of these pathogens in order to better assess any potential for
autochthonous transmission to people living in the region.
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Chapter 1: Background and Significance
1.1 Leishmaniasis
Protozoal parasites of the genus Leishmania represent one of the more ancient and
genetically diverse taxa of all eukaryotic human pathogens. Belonging to class Kinetoplastida,
the Leishmania are intracellular, haemoflagellate, multi-host protozoans that belong to the same
family (i.e., the Trypanosomatide) as the important human parasites Trypanosoma cruzi and
Trypanosoma brucei (Stevens et al, 2001). The disease caused by Leishmania protozoa, termed
leishmaniasis, can range from relatively benign, ulcerative skin lesions to severe hepatomegaly
and splenomegaly that is almost invariably fatal if left untreated.
The genus Leishmania is known to comprise an estimated 35 genetically distinct species,
over 20 of which have been linked to human disease (World Health Organization, 2014). This
substantial diversity among the Leishmania is due to their lengthy evolutionary history (likely
established over 50 million years ago) that has allowed for both the distribution of these parasites
across the world and for their divergence and speciation within several ecological settings (Tuon
et al, 2008). The genus Leishmania can be taxonomically subdivided into two major subgenera
containing all Leishmania species known to parasitize humans and cause disease, and two
putative subgenera with species not recognized as human pathogens (Figure 1). The two major
subgenera, Leishmania Leishmania and Leishmania Viannia, divide the genus based on ancient
evolutionary origins in either the Old World or New World, respectively, and contain all known
leishmanial pathogens of humans. Species in the Leishmania Leishmania subgenus can be
categorized into three major species complexes, the L. donovani complex, the L. tropica
complex, and the L. mexicana complex (Britto et al, 1998). Although part of the Leishmania
Leishmania subgenus (with evolutionary origins in the Old World), the L. mexicana complex
now contains parasites found exclusively in the Americas (Bates, 2007). Species of the
Leishmania Viannia subgenus are exclusively found in the New World, distributed throughout
South and Central America (Lainson and Shaw, 2005). Two other subgenera, Leishmania
1

Sauroleishmania and Leishmania Endotrypanum contain parasites of lizards and sloths,
respectively, and are not of medical importance to humans (Croan and Ellis, 1996) (Figure 1).

Figure 1: Diagrammatical taxonomic breakdown of medically relevant species in Genus
Leishmania. Species within the subgenera L. Leishmania and L. Viannia are
subdivided based on their geographic occurrences and the major clinical disease
they cause. (CL: cutaneous leishmaniasis; MCL: mucocutaneous leishmaniasis; VL:
visceral leishmaniasis) *Species of these subgenera are not known to infect humans.
Figure by E. Kipp (Adapted from Bates, 2007)

Collectively referred to as leishmaniases, the disease caused by Leishmania infection can
present in a variety of clinical forms in people and is responsible for significant morbidity and
mortality in tropical and sub-tropical nations throughout the world. In people, clinical disease
2

caused by Leishmania typically presents in one of three major forms: visceral leishmaniasis,
cutaneous leishmaniasis, or mucocutaneous leishmaniasis. Development of one of these three
disease phenotypes is primarily determined by the species of Leishmania causing the infection,
but can also be influenced by the ecological setting in which infection occurs, by the strength of
the host’s immune response, and by other complex host-parasite interactions (McCall and
McKerrow, 2014).
Visceral leishmaniasis (VL), the most serious manifestation of the disease, is typically
caused by the parasites L. donovani, L. infantum, and L. chagasi and is almost invariably fatal if
left untreated. Onset of symptoms can be sudden or gradual, and usually occurs approximately 3
to 6 months after initial exposure (Despommier et al, 2000). Patients with VL often present with
fever, abdominal discomfort, cachexia, diarrhea, and hepatosplenomegaly (Guerin et al, 2002).
Involvement and enlargement of the spleen and liver is a defining feature of the disease, often
resulting in significant abdominal distension, and is due to the preferential metastasis of
Leishmania-infected macrophages to these organs (Meddeb-Garnaoui et al, 2008). Replication of
Leishmania parasites in VL patients can also result in bone marrow suppression, pancytopenia,
potential secondary infection, and ultimately leads to death if left untreated (McGwire and
Satoskar, 2013).
The majority of known pathogenic Leishmania throughout the world cause a form of the
disease known as cutaneous leishmaniasis (CL) in which a sometimes large, ulcerative lesion
will erupt on the skin near the site of the sand fly bite wound. These cutaneous lesions often
become apparent between two to eight weeks after initial exposure to the pathogen and begin as
small, painless, erythematous papules that progressively become larger and eventually ulcerate
and depress to reveal a sizeable crateriform lesion that can often be over 5 cm in diameter.
(Despommier et al, 2000). Full progression from papule to ulcer can take anywhere between two
weeks to nearly six months and can vary significantly in size, outward appearance and in the
amount of time needed for healing to occur (Reithinger et al, 2007). CL will often spontaneously
resolve, even in the absence of antiprotozoal chemotherapy, but may take anywhere between 2
3

and 15 months depending on numerous host factors and the species of parasite causing the
infection (Bailey and Lockwood, 2007). In cases of spontaneous healing, individuals are often
protected against future infection from the same Leishmania sp. but may still be susceptible to
infection by other Leishmania spp. (Reithinger et al, 2007). Even after healing, significant
scarring and permanent disfigurement may result which may have a serious negative social or
economic impact on the part of the afflicted individual. In many settings where CL is endemic,
children are at greater risk of being infected than their adult counterparts and also have a greater
risk of developing lesions on the exposed and hairless portions of their head or face where the
resulting scar can be severely disfiguring (Armijos et al, 1997). For people living in endemic
areas these scars can also have a lifelong psychological impact. Large scars on an individual’s
face or another visible part of the body can have a significant negative psychosocial impact and
can greatly reduce an individual’s self-esteem. These negative psychosocial impacts are
especially common among women in endemic areas who often report that having scars as a
result of CL lowers their perceived attractiveness, reduces their marriage prospects, and results in
significant social stigmatization within their respective communities (Weigel et al, 1994). Adult
males, on the other hand, living in endemic areas are more likely to view CL as a disease that can
have a significant economic impact, as they are more likely to develop lesions and scars on their
hands, feet, or limbs that interfere with their daily occupational activities (Weigel et al, 1994).
Mucocutaneous leishmaniasis (MCL) is a form of the disease limited to Central and
South America and typically caused by members of the L. Viannia subgenus, most often L.
Vianna braziliensis and L. Vianna panamensis. In this form of the disease, Leishmania-infected
macrophages preferentially metastasize to the mucosa of the oral cavity and nose, ultimately
leading to the progressive erosion of these body parts and severe disfigurement and morbidity
(Lainson and Shaw, 2005). In a large majority of cases, MCL is secondary to the cutaneous form
of the disease, often erupting many months or years after the apparent spontaneous resolution of
the initial cutaneous lesion. In these cases of MCL secondary to CL, Leishmania-infected
macrophages may survive for extended periods of time within the human host without causing
4

noticeable disease and ultimately reactivating and metastasizing to the oral and nasal mucosa in a
small percentage of those infected (i.e., less than one percent of those initially infected with
MCL prone Leishmania spp.) (Lainson and Shaw, 2005; Lessa et al, 2007). Appropriate
treatment of initial CL can significantly reduce an individual’s risk of developing secondary
MCL. There have been numerous reports, however, of latent CL infections following
antiprotozoal reactivating months or years later as MCL, although this reactivation is far more
likely to occur in those that receive no treatment or do not adhere to the entire treatment regimen
(Weigle and Saravia, 1996). Complications due to MCL can be very severe and debilitating and
can include blockage of the nasal passage leading to respiratory distress, a greater likelihood of
developing potentially lethal pulmonary infections, and significant facial disfigurement that
arises as a result of the erosion of the nasal and oral mucosa (Lainson and Shaw, 2005).
Another less common manifestation of leishmaniasis in humans is known as diffuse
cutaneous leishmaniasis. This diffuse (or disseminated) form of the disease can be caused by
multiple species of Leishmania parasites but is most often due to L. mexicana infection in
immunocompromised individuals. Cases of diffuse cutaneous leishmaniasis are characterized by
the development of small and nonulcerative papules that may erupt across the entirety of the
host’s skin (Reithinger et al, 2007). In these cases of diffuse cutaneous leishmaniasis,
Leishmania parasites proliferate widely throughout the body and are consistently resistant to any
antiprotozoal chemotherapy, making cure of this form of the disease often unachievable (Convit
et al, 1972).

1.1.1 Pathobiology of Human Cutaneous Leishmaniasis
All species of Leishmania, including those that cause CL, have obligate life cycle stages
in a phlebotomine sand fly vector and in a mammalian host. Transmission of the protozoa
between vector and host occurs when the female sand fly takes a blood meal from a human or
other mammalian species capable of harboring the parasite.
5

Humans are initially exposed to a flagellated form of the parasite, known as the
promastigote that gets injected into the subcutaneous tissue when an infected female sand fly
takes a blood meal (Figure 2). Tissue macrophages encounter the promastigote and proceed to
engulf it, initiating a series of biochemical changes that result in its transformation into an
aflagellate and intracellular form, known as the amastigote (Figure 2). These intracellular
amastigotes replicate rapidly via binary fission within the macrophage (inside a specialized
organelle called the phagolysosome) ultimately causing it to burst and release amastigotes into
the surrounding tissue where they are free to infect new macrophages (Despommier et al, 2000).
In CL, infected macrophages are often only found in areas of the skin immediately surrounding
the raised edge of the cutaneous lesion or in the adjacent lymphatic drainage. Only in VL, MCL
or diffuse cutaneous leishmaniasis do the parasites travel to distant sites or infect the body’s
deeper organs (Bailey and Lockwood, 2007).

Figure 2: Leishmania parasites under light microscopy. (A) Amastigotes visible as darkly stained
granules within Giemsa-stained macrophages. (B) Promastigotes in liquid culture.
Images adopted from CDC Public Health Image Library
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A female sand fly becomes infected with Leishmania when it ingests free amastigotes in
the blood or infected tissue macrophages containing intracellular amastigotes. In the gut tract of
the sand fly, chemical cues cause the parasite to change into its flagellated promastigote form in
a period of about a week. Eventually these new, infective metacyclic promastigotes will migrate
to the sand fly’s salivary glands. The cycle is completed when the female sand fly takes a second
blood meal from a human or other mammal and injects infective promastigotes into the bite
wound along with its salivary secretions (Despommier et al, 2000) (Figure 3).

Figure 3: Lifecycle of Leishmania within the human host. Figure adopted from the CDC
Division of Parasitic Diseases and Malaria
7

1.1.2 Biology of Phlebotomine Vectors
All forms of human leishmaniasis are transmitted via the bite of a female phlebotomine
sand fly (Diptera: Psychodidae: Phlebotominae) belonging to either the genus Phlebotomus or
the genus Lutzomyia. Phlebotomus spp. are responsible for transmission of Old World
leishmaniasis throughout Europe, the Middle East, Africa and Asia, and Lutzomyia spp. are
responsible for transmission of the disease throughout the Americas (Reithinger et al, 2007).
Approximately 700 species of sand fly have been described to date, only about 10% of which are
known to be competent vectors of human leishmaniasis (Bates, 2007). In some settings, sand
flies have also been identified as competent vectors of Bartonella bacteria and numerous
arboviruses (Young and Duncan, 1994).
The sand fly life cycle begins when a female sand fly lays her eggs in a humid habitat
often with ample decaying organic material (e.g., forest leaf litter, rock crevices, animal
burrows). About ten days after oviposition, the sand fly eggs will hatch into small caterpillar-like
larvae that feed on available organic material. After a period of a few weeks to months, these
larvae will transform into pupae and attach themselves to a solid object such as a stone or dead
leaf. Adult sand flies then emerge about 7 to 12 days later. Both male and female sand flies
require a carbohydrate energy source that they may obtain from floral nectar, fruits, honeydew
from aphids, or other plant material. Female sand flies require an additional vertebrate blood
meal for the maturation of their eggs. Biting preferences differ substantially between different
sand fly subgenera and species and can include a wide variety of mammalian, avian, amphibian,
or reptilian species (Young and Duncan, 1994). Transmission of Leishmania parasites between
mammalian hosts requires a female sand fly to take at least two blood meals, one in which
Leishmania amastigotes are taken up from an infected animal and a second blood meal in which
infectious promastigotes are inoculated into a naïve mammalian host (Despommier et al, 2000).
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1.1.3 Mammalian Reservoirs of Cutaneous Leishmaniasis and Leishmaniasis in Canines
Leishmania parasites have been isolated from a variety of non-human mammalian hosts
in different settings throughout the world, likely acting in widely different capacities as
reservoirs. Mammalian hosts include numerous rodent species, marsupials, sloths, armadillos,
domestic and wild canines, cats, and various other carnivorous mammals (Reithinger et al, 2007;
Esch and Petersen, 2013). Within these mammalian hosts, infection with Leishmania spp. may
cause asymptomatic infection or result in clinical disease that may or may not mirror the clinical
forms of leishmaniasis in humans. For example, dogs infected with Leishmania infantum present
with a distinct viscero-dermic form of disease in which the parasite can be detected in visceral
organs as well as in intact and apparently healthy skin. Additionally, rodents infected with
Leishmania spp. responsible for the cutaneous form of the disease in humans can have detectable
parasites in their deep visceral organs (Roque and Jansen, 2014).
Mammalian reservoirs for leishmaniasis have been classically divided into one of three
categories: primary reservoirs, secondary reservoirs, and incidental hosts. Primary reservoirs are
defined as those that can harbor the infection and transmit it back to phlebotomine vectors in
endemic settings in such a way that the amplification and transmission of the parasite is largely
favored (i.e., with a basic reproduction number greater than one) (Reithinger and Davies, 1999).
Additionally, an effective primary reservoir must have a natural history that puts them in regular
contact with the hematophagous sand fly vector, must be able to carry the parasite for long
periods of time while being asymptomatic or without developing debilitating disease, and must
be known to carry the parasite in areas adjacent to where human cases have been reported
(González et al, 2010). Secondary reservoirs are those that can significantly aid in the
transmission of the parasite in the presence of other mammalian reservoirs but that are unable to
act as primary reservoirs in the absence of these other host species. Finally, incidental hosts are
those whose infection with the parasite may cause clinical illness but are unable to facilitate
long-term transmission back to the phlebotomine vector population (Reithinger and Davies,
1999).
9

The role of domestic dogs (Canis familiaris) in the transmission of CL in the Americas is
of particular interest. In endemic foci throughout the Americas, it has been established that
numerous species of rodent, sloth, and other sylvatic mammalian species can act as primary
reservoirs for Leishmania. Infection in domestic dogs is well-documented with positive dogs
having been identified in Bolivia, Brazil, Colombia, Ecuador, Panama, Peru, Venezuela, and the
United States (Reithinger and Davies, 1999). Whether these infected dogs are acting as
secondary reservoirs or only as incidental hosts in these settings is still a topic of debate.
However, dogs may be playing a very interesting epidemiological role in some of these settings
through their close associations with humans. It remains a possibility that dogs could be acting as
something of a “bridge reservoir”, bringing Leishmania from sylvatic, enzootic cycles into areas
more densely populated with humans and where transmission to people is more likely to occur
(Esteve-Gassent et al, 2014).

1.1.4 Diagnosis and Treatment of Human Cutaneous Leishmaniasis
Human CL can be very difficult to appropriately diagnose in many rural settings or
endemic areas with limited medical infrastructure. Physicians throughout the Americas should
consider CL in their differential diagnosis in cases of problematic ulcerative skin lesions that do
not respond to topical antibiotic treatment. Unfortunately, the clinical presentation of CL can be
similar to that of some skin cancers, leprosy, cutaneous tuberculosis, and various fungal
infections. A more specific diagnosis not based on clinical presentation alone is needed to
confirm the diagnosis of CL and to begin antiprotozoal treatment (Reithinger et al, 2007).
A definitive diagnosis can be obtained through the observation of Giemsa-stained
Leishmania parasites under microscopic examination, either through tissue smears or
parasitological culture. Direct diagnosis of CL through microscopic examination has a somewhat
low sensitivity and often only works well only in the early stages of the infection when
Leishmania amastigotes are widely circulating in the area surrounding the skin lesion.
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Parasitological culture has a greater sensitivity than microscopic observation, but is often not an
available tool in many rural clinics in endemic settings and also has a lower sensitivity in cases
of chronic CL (Reithinger et al, 2007). For diagnosis of CL infections that have persisted for
many months, PCR detection of Leishmania from ulcer biopsies can greatly improve diagnostic
sensitivity but also is not a readily available diagnostic tool in rural endemic areas that lack
adequate medical and laboratory infrastructure (Reithinger et al, 2007). Another diagnostic
method, known as the Montenegro skin test, is used in some endemic areas in which a small
amount of leishmanial antigen is injected subcutaneously and observed for localized
inflammatory response (i.e., any swelling, itching, redness, or heat) indicative of previous
exposure to the pathogen. The Montenegro skin test has proved itself a useful diagnostic tool for
identifying cases of MCL and chronic CL due to the strong host immune response that is elicited.
While this can be both a sensitive and specific method for diagnosis, it is rarely used outside of
epidemiologic studies in endemic areas, and it is unable to distinguish between a current
Leishmania infection or previous exposure to the pathogen (Reithinger et al, 2007; Calvopina et
al, 2004).
Despite the tendency of many CL lesions to spontaneously heal, treatment of the disease
is often necessary, especially in cases of large, persistent, or debilitating lesions. Rapid diagnosis
and treatment is especially necessary in children with CL, as the cutaneous lesions are more
likely to be in the head or face area and have a tendency to grow rapidly due to their small body
size (Armijos et al, 1997; Armijos et al, 1998). Additionally, treatment of CL is often necessary
to reduce the risk of recurrent CL, known as leishmaniasis recidivans, in which cutaneous lesions
can erupt months or years after an apparent spontaneous cure of CL near the site of the original
lesion (Bailey and Lockwood, 2007).
Treatment of CL usually involves administration of a pentavalent antimonial compound,
the most common of which is sodium stibogluconate. The Word Health Organization
recommends intralesional, intramuscular or intravenous administration of sodium stibogluconate
(20 mg/kg) for 20 to 28 consecutive days (World Health Organization, 2014; Reithinger et al,
11

2007). For most Leishmania spp., cure rates of between 85 and 95% are observed after
administration. Despite its efficacy, sodium stibogluconate treatment can be associated with a
number of serious adverse side effects including severe headache, rash, arthralgia, myalgia,
pancreatitis, and liver damage (Despommier et al, 2000).
Numerous other alternative treatments against CL are also available with varying degrees
of efficacy. Amphotericin B is an antifungal drug that is often administered in cases of VL
(caused by L. infantum), MCL, or in cases of CL where sodium stibogluconate administration is
contraindicated (Reithinger et al, 2007). Amphotericin B is most often delivered within lipid
formulations or encapsulated in liposomes in order to improve its overall efficacy and to increase
its selectivity at killing protozoal cells. Clinical studies have shown liposomal Amphotericin B to
be very efficacious for the treatment of leishmaniasis and despite some toxic side effects
(especially to the renal system) it may ultimately offer a more effective and safe alternative to the
traditional antimonial treatment regimen (Amato et al, 2004).
Currently there are no readily available human vaccines against any form of
leishmaniasis, although numerous vaccine candidates have shown success in human and animal
models. Leishmanization, a process in which live and virulent parasites are intentionally
inoculated into an inconspicuous area of the body to cause CL and provide long lasting
immunity, has been practiced for centuries in some endemic areas (Dunning, 2009). More recent
studies using attenuated or killed parasite vaccines, recombinant protein vaccines, and third
generation DNA vaccines have shown experimental efficacy, raising the prospect that a human
vaccine against CL will become available in the future (Dunning, 2009; Armijos et al, 2004).

1.1.5 Epidemiology of Leishmaniasis
Human leishmaniasis is widely distributed throughout the world with autochthonous
transmission having been described in 98 countries on all continents, excluding Australia and
Antarctica (Alvar et al, 2012). The World Health Organization estimates that over 350 million
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people around the world are at risk for contracting at least one form of leishmaniasis. The vast
majority of leishmaniasis-associated mortality is due to VL, primarily caused by L. donovani, L.
infantum, and L. chagasi. Up to 500,000 people are affected by VL each year and between
40,000 and 59,000 deaths are recorded annually (Ready, 2014; Alvar et al, 2006). Among all
parasitic diseases, VL is second only to malaria in number of annual deaths. Collectively,
leishmaniasis also has a significant economic impact worldwide. Approximately 2.1 million
disability-adjusted life years are lost annually due to all forms of leishmaniasis and with 44,000
of these lost life years coming from Latin American nations alone (Hotez et al, 2008).
Although not a significant cause of mortality, CL is a major infectious cause of morbidity
throughout the world’s tropics and subtropics. Worldwide, CL has an estimated annual incidence
of between 700,000 and 1.3 million cases, with 95% of those cases occurring in the Americas,
the Middle East, the Mediterranean basin, and Central Asia (World Health Organization, 2014).
In the Americas, 59 million people live at risk of contracting CL and there is an estimated annual
incidence of approximately 59,300, though this figure may be significantly higher as the disease
often goes unreported in many areas where access to medical care is limited (Weigle and
Saravia, 1996). The distribution of CL in the New World extends throughout South and Central
America, into Mexico and even into the southern United States (Lainson and Shaw, 2005).
Risk factors for contracting CL throughout the world can differ widely depending on
numerous epidemiologic variables across different endemic regions. Some common risk factors
for contracting the disease include sex (males typically have jobs or social roles that put them in
increased contact with phlebotomine vectors), age (older people in endemic areas often have
developed some degree of immunity), household construction, and the presence of domestic or
peri-domestic animals living in close association with people (Reithinger et al, 2007). Other
important risk factors for the development CL, especially in the New World, are the degree of
deforestation, agricultural development, and resource exploitation in a given area. The
degradation of a landscape can often cause phlebotomine vectors to adopt a more anthrophilic
lifestyle whereby they bite humans and domestic animals more regularly than they would if the
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landscape around them was intact and other sylvatic mammal species were more abundant
(Desjeux, 2001). CL is also a disease closely associated with poverty and the lack of adequate
medical infrastructure. Poverty-associated factors such as poor housing conditions, poor
nutrition, lack of bed net usage, sleeping outside, lack of regular garbage collection, and
inadequate vector control efforts all are greatly associated with increased risk for contracting CL
(Alvar et al, 2006).

1.1.6 Emergence of Cutaneous Leishmaniasis in the United States
Between 1903 and 1996, approximately 29 reported cases of autochthonous human CL
were reported in the United States, all from the state of Texas (Clarke et al, 2013). In 2008, a
cluster of 9 autochthonous cases of CL was reported in north Texas in an area that had
previously never had any evidence of Leishmania transmission, possibly indicative of a recent
northward expansion of the disease (Wright et al, 2008). In all recent cases of human CL in
Texas, the pathogen responsible has been L. mexicana, a species that most often causes CL but is
also known to cause diffuse cutaneous leishmaniasis in a small subset of infected individuals.
Recent research has also indicated that the primary reservoir of CL in south, central and north
Texas is likely the Southern Plains woodrat (Neotoma micropus). Infected woodrats have been
discovered in the vicinity of all recent documented human exposures and also in areas of the
state where human cases have not yet been reported (McHugh et al, 1990; Raymond et al, 2003;
González et al, 2010).
Reports of CL in domestic dogs in Texas have also been reported, though these have not
been backed up by molecular testing and to date no comprehensive seroprevalence or PCRprevalence study testing for L. mexicana has been conducted in the state (Petersen, 2009).
Outbreaks of canine leishmaniasis caused by L. infantum among hunting dogs imported from the
Mediterranean basin have also occurred throughout the U.S. since 1999. Although no
autochthonous human cases of VL caused by L. infantum have been reported, it has been shown
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that dogs can act as capable reservoirs of this parasite and evidence for local transmission
between dogs in the U.S. has been well-documented (Enserink, 2000; Petersen, 2009).
Evidence also suggests that in future years, the distribution of CL across the state of
Texas and across the entire southern United States will expand significantly, in large part due to
climate change-mediated factors. Predicted reservoir distributions created using ecological niche
modeling under various climate change scenarios suggest a widening and northwardly expansion
of the reservoir species Neotoma micropus, Neotoma albigula, Neotoma floridana, and Neotoma
mexicana. Also the same predictive modeling applied to the endemic phlebotomine vector
species, Lutzomyia anthophora and Lutzomyia diabolica, also predicts a widening and
northwardly expansion (González et al, 2010). In addition to climate change, other factors
associated with the emergence of CL into new regions of the United States and into areas where
humans will be at greater risk of infection might include habitat destruction, increased tourism
and immigration, environmental pollution, insecticide resistance, and increasing human
encroachment into uninhabited and rural areas (Harrus and Baneth, 2005).
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1.2 American Trypanosomiasis (Chagas Disease)
The genus Trypanosoma (Kinetoplastida: Trypanosomatidae) contains two notable
human pathogens, Trypanosoma cruzi and Trypanosoma brucei, the cause of Chagas disease
(American trypanosomiasis) and African sleeping sickness (African trypanosomiasis),
respectively. In addition to these two important human pathogens, the genus Trypanosoma also
contains numerous other protozoa that are known to parasitize animals of all vertebrate classes
(Haag et al, 1998). Trypanosome parasites also differ widely in their pathobiology and can be
transmitted by a variety of vectors including numerous species of insect, arachnid, and even
some leeches (Haag et al, 1998). Even between the two major human trypanosomiases, there are
significant differences in transmission and pathobiology with T. cruzi being transmitted by the
triatomine (i.e., kissing bug) and being an intracellular infection in its mammalian host, and T.
brucei being transmitted by the dipteran Tse-tse fly and being an extracellular infection in its
host. Indeed, these two trypanosome species have likely been geographically isolated for
millions of years and have had ample evolutionary time to diverge and develop their strikingly
different life cycles (Machado et al, 2006).
Human infection with T. cruzi, the causative agent of Chagas disease, can lead to a broad
spectrum of clinical symptoms depending on the length and burden of infection, the type of
tissue most affected by the parasite, and by numerous other host and parasite factors
(Despommier et al, 2000). Clinical Chagas disease can, however, usually be divided into three
phases: an initial acute phase, a prolonged indeterminate phase, and a final symptomatic chronic
phase. Acute infection with T. cruzi can be asymptomatic or is sometimes characterized by fever,
malaise, and lymphadenopathy. These symptoms of acute Chagas disease are often transient and
can easily be misdiagnosed. Acute Chagas disease is most common in young children and can
even be fatal if serious complications develop, such as meningitis, encephalitis, myocarditis or
pneumonitis (Rassi Jr et al, 2010). After an acute incubation period of between 4 and 12 weeks,
an infected individual will enter an asymptomatic or indeterminate phase of that can last many
years or decades. Finally, an individual may progress into the chronic phase of Chagas disease
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that is responsible for the vast majority of the disease’s observed morbidity and mortality.
Progression to this symptomatic stage occurs in an estimated 30% to 40% of those
asymptomatically infected and is most often characterized by the progressive destruction of the
myocardium, the esophagus, or the colon (World Health Organization, 2015; Rassi Jr et al,
2010). Chagas disease-associated morbidity and mortality can be due to a number of causes
including myocarditis, congestive heart failure, arrhythmia, thromboembolism, megaoesophagus,
and megacolon (Rassi Jr et al, 2010; Tanowitz et al, 1992).
In addition to the traditional vector-borne route of transmission for T. cruzi, infection can
also occur when the parasite comes in contact with a host’s ocular or conjunctival membrane or
is directly ingested. In cases of vector-borne transmission, a large swollen and erythematous area
may develop around the site of the triatomine bite wound and known as a chagoma. If the
parasite is introduced into the body through contact with the ocular membrane, a unilateral
swelling may develop around the eye, referred to as Romaña’s sign (Despommier et al, 2000).
Transmission of T. cruzi via blood transfusion, organ transplant, from mother to offspring, and
through the ingestion of uncooked food contaminated with infected triatomines has also been
documented, though with far less frequency and epidemiologic relevancy than traditional vectorborne transmission. (World Health Organization, 2015).

1.2.1 Pathobiology of Chagas Disease
Infection with T. cruzi begins when a human is bitten by an infected triatomine. Rather
than inoculating the infective parasites directly into the bite wound, however, the triatomine will
actually defecate in the area surrounding the bite wound and release a flagellated T. cruzi
trypomastigote, the infective stage of the parasite, in its feces (Figure 4). The bitten human or
other mammalian host will often then proceed to rub or scratch at the bite wound, driving these
infective metacyclic trypomastigotes into the subcutaneous tissue. In some cases, the bitten
individual will rub or scratch the bite wound and proceed to touch their eyes, allowing the
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parasite to gain entry to the body through the conjunctiva or ocular membrane. Once inside the
host, these metacyclic trypomastigotes can directly penetrate a number of different host cell
types, and once inside a host cell will lose their flagellum and transform into the amastigote stage
(Figure 4). These intracellular amastigotes will proceed to divide within the host cell, eventually
transforming into trypomastigotes that burst from the host cell and enter the host bloodstream.
Once in the bloodstream trypomastigotes can travel to and infect distant tissues, often showing a
proclivity for myocardiocytes and cells of the hollow digestive organs. In these tissues the
parasite will transform back into the amastigote where it can then replicate or lay dormant for
many years, and may eventually lead to symptomatic chronic Chagas disease (Despommier et al,
2000) (Figure 5).

Figure 4: Trypanosoma cruzi parasites under light microscopy. (A) Cluster of intracellular
amastigotes visible in central myocardiocyte. (B) Trypomastigote in peripheral
blood smear. Images adopted from CDC Public Health Image Library

It has been observed that different strains of T. cruzi vary in their tropism for different
tissues. Studies in mice have identified some T. cruzi strains with a proclivity for spleen, liver, or
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bone marrow, some with a proclivity for myocardiocytes, and others that preferentially infect the
smooth muscle of hollow digestive organs (Melo and Brener, 1978). The various strains or
discrete typing units of T. cruzi that have been identified are also known to have somewhat
varying degrees of tissue tropism that ultimately may affect the clinical manifestations of chronic
Chagas disease in those infected. For example, TcI (a discrete typing unit found throughout the
Americas and into Mexico and the United States) has been shown to be more prone to cause
cardiac manifestations than some of the other T. cruzi discrete typing units, however
gastrointestinal complications caused by this parasite can still be observed (Espinoza et al, 2011).
The “kissing bug” vector becomes infected when it feeds on an acutely infected
mammalian host and ingests circulating trypomastigotes from the host’s bloodstream. Within the
triatomine vector, the newly ingested trypomastigotes will transform into epimastigotes in the
vector’s midgut and replicate via binary fission. Eventually, the epimastigotes will migrate to the
vector’s hindgut and rectum where they transform back into the infectious stage, the metacyclic
trypomastigote that can now be transmitted to an uninfected mammalian host following a blood
meal (Rassi Jr et al, 2010; Despommier et al, 2000) (Figure 5).
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Figure 5: Lifecycle of Trypanosoma cruzi within the human host. Figure adopted from the U.S.
Centers for Disease Control and Prevention

1.2.2 Biology of Triatomine Vectors
Trypanosoma cruzi is most often transmitted to human and other mammalian species
thorough the bite of an infected triatomine “kissing bug” (Hemiptera: Reduvidae: Triatominae).
Currently, there are 140 different species of triatomine that have been formally described and
although all are likely competent carriers of T. cruzi, many species may have natural histories
that do not make them epidemiologically relevant vectors of human Chagas disease (Schofield
and Galvão, 2009). Indeed, many triatomine species differ greatly in their anthropophily, biting
preferences, and time between feeding and defecation, all of which can affect their competency
as Chagas disease vectors (Stevens et al, 2011). Nearly all triatomines are found in the New
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World in tropical, subtropical and temperate regions extending in latitude from approximately
46º N to 46º S. Common names for triatomines differ greatly across the Americas and include
the “kissing bug”, the “chinche”, the “chinchoro”, and the “vinchuca”, among numerous others
(Schofield and Galvão, 2009).
Triatomines are considered true bugs, and all are six-legged and winged as adults with
narrow heads and elongate bodies. Many also have an elaborate orange or yellow banding
pattern surrounding their abdomen that can often serve as a distinguishing feature. Species in
three genera, the Triatoma, the Rhodnius, and the Panstrongylus, have been implicated as
important T. cruzi vectors. All of these vector species (both male and female) are secretive and
nocturnal, and feed on the blood of a variety of vertebrate species (Stevens et al, 2011).
About 40 Triatoma spp. are found in North America, with eight species being shared
between the United States and Mexico, 28 being found only in Mexico, and four being found
exclusively in the United States (Stevens et al, 2011). In the United States, triatomines can be
found from California to Florida, and as far north as Pennsylvania and New Jersey, though much
of the species diversity is contained in the southern United States and within the state of Texas
(Klotz et al, 2014). Triatoma gerstaeckeri, Triatoma protracta, Triatoma indictiva, Triatoma
rubida, Triatoma lecticularia, Triatoma neotomae, Triatoma recura, and Triatoma sanguisuga
are all species that have been identified in different regions throughout the state (Klotz et al,
2014). The overall T. cruzi infection rate among triatomines is also higher in Texas than in any
other state, with infection rates of greater than 50% being reported by some studies (McPhatter et
al, 2012; Kjos et al 2009).

1.2.3 Mammalian Reservoirs for Trypanosoma cruzi and American Trypanosomiasis in
Canines
More than 150 species of domestic and sylvatic mammals have been found with evidence
of T. cruzi infection worldwide, including domestic dogs, cats, guinea pigs, many different
rodents, armadillos, and some marsupials (Rassi Jr et al, 2010). In many remote and uninhabited
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settings, enzootic transmission cycles of the disease are restricted to rodent species, primates,
opossums, armadillos, and other sylvatic wild mammals with only incidental infection of
domestic animals or humans reported. In peri-domestic and domestic settings, however, infection
is much more common in domestic dogs, cats, some synanthropic rodent species, and as a
consequence, humans (Gürtler and Cardinal, 2015).
In the United States, T. cruzi has been detected in raccoons, skunks, opossums, and a
wide variety of rodent species (Charles et al, 2013; Bern et al, 2011). A recent seroprevalence
study conducted across Texas found an 8.8% seropositivity among stray shelter dogs, with a
6.9% seropositivity being found in shelter dogs in the El Paso region (Tenney et al, 2014).
Clinical infection in domestic dogs is somewhat similar to that in humans, with an initial
acute phase and long indeterminate or asymptomatic phase. Mortality can be especially high in
dogs less than one year old, often due to various cardiac complications. Many dogs exhibit a high
parasitemia a few days following initial infection and lasting up to a month, making them
potentially effective reservoirs of the disease in some settings and capable of transmitting the
infection back to triatomines. Differences in the clinical outcome and potential infectivity of
infected dogs vary greatly by age, breed, nutritional status, and the T. cruzi strain or discrete
typing unit causing infection (Gürtler and Cardinal, 2015; Kjos et al, 2008; Bern et al, 2011).

1.2.4 Diagnosis and Treatment of Chagas Disease
Definitive diagnosis of acute Chagas disease often requires microscopic observation of
circulating bloodstream trypomastigotes. Detection of circulating bloodstream parasites becomes
much more difficult during the indeterminate or chronic phases of the disease, as most parasites
exist in the host in the form of intracellular amastigotes (Despommier et al, 2000). Diagnosis of
Chagas disease in the chronic phase usually requires the detection of IgG antibodies against T.
cruzi (detected through either ELISA, immunofluorescence, or indirect haemagglutination). PCR
diagnosis of chronic Chagas disease is not widely employed as a diagnostic tool due to recurring
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problems with sensitivity, standardization, cross-contamination, and the need for more
sophisticated laboratory infrastructure that is not available in many resource-limited settings
(Rassi Jr et al, 2010; Bern et al, 2011).
Chagas disease is traditionally treated with the antiprotozoal drugs benznidazole and
nifurtimox. If given to an individual soon after infection these drugs can be highly efficacious
with cure rates approaching 100% (World Health Organazation, 2015). However, cure rates are
significantly diminished in cases of chronic infection. Despite this, treatment of infected
individual in the indeterminate or chronic phase of the disease is often recommended as it can
halt the progression of the disease and limit development of more severe symptoms (World
Health Organization, 2015; Despommier et al, 2000). No human vaccine against T. cruzi is
currently available despite a great need for one. Modern vaccination techniques such as DNA
vaccination, recombinant protein vaccination, and carbohydrate vaccination have shown some
experimental success, raising the prospects that a vaccine will be available in future years
(Camargo, 2009).

1.2.5 Epidemiology of Chagas Disease
Transmission of T. cruzi occurs almost exclusively within Latin America and the
southern United States, however numerous infections have been reported in returning travelers or
migrants in the northern United States, Canada, throughout Europe, and in nations of the western
Pacific (Rassi Jr et al, 2010). An estimated 25 million people are at risk for infection with T.
cruzi and an estimated 6 to 7 million individuals are believed to be actively infected worldwide,
with the majority of infections being in Central America, South America, or Mexico (World
Health Organization, 2015). Other estimates propose these figures to be much higher, with some
studies estimating the overall prevalence to be as high as 17 million, the estimated incidence to
be as high as 700,000-800,000 new cases annually, and the annual number of Chagas diseaserelated deaths to be as high as 45,000 (Moncayo and Silveira, 2009).
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Across the Americas, T. cruzi parasites can be subdivided into six different discrete
typing units referred to as TcI through TcVI. Each different discrete typing unit varies in its
geographic distribution across the Americas, in its preferred mammalian hosts and triatomine
vectors, in the ecological environment in which it is found, and in the clinical Chagas disease
symptoms it causes in humans (Zingales et al, 2012) (Figure 6). Two discrete typing units are
known to be endemic to the southern United States, TcI and TcIV, where both appear to be
primarily infecting sylvatic mammal species with only incidental infection of domestic animals
or humans being reported (Zingales et al, 2010; Charles et al, 2013).

Figure 6: Geographic distribution of Trypanosoma cruzi by discrete typing unit. Figure adopted
from Zingales et al, 2012
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In South and Central America, the Chagas disease burden is heaviest in the nations of
Brazil, Argentina, Bolivia, Colombia, Venezuela and Ecuador. In Brazil and Argentina alone, an
infection prevalence of 1.9 million and 1.6 million has been estimated, respectively (Bern et al,
2011). In Mexico, Chagas disease has an estimated annual incidence of approximately 70,000
cases and seroprevalance studies have proposed an estimated overall infection prevalence of
about 1 or 2 million people (Carabarin-Lima et al, 2013; Hotez et al, 2013). Estimates of T. cruzi
infection prevalence in the United States vary significantly and to date no estimates have been
able to distinguish between imported and autochthonous cases. The highest estimates of Chagas
disease prevalence in the United States report an estimated 1 million infections, with Texas alone
having an estimated 267,000 infections (Hanford et al, 2007). More conservative estimates place
the overall number of infected individuals in the United States closer to 300,000 (Bern and
Montgomery, 2009; Sarkar et al, 2010). Again, these estimates have the limitation in that they do
not distinguish between travel-associated and autochthonous cases, and an estimate of the
number of autochthonous Chagas disease cases in the United States or in Texas has not yet been
made available.

1.2.6 Emergence of Chagas Disease in the United States
The first case of autochthonous Chagas disease in the United States was described along
the Texas-Mexico border in 1955. However, the disease has likely been present along the Rio
Grande Valley for many thousands of years (Bern et al, 2011; Hotez et al, 2013). Despite
conservative estimates of approximately 300,000 cases of Chagas disease currently present in the
United States, the number of confirmed autochthonous cases has remained quite low. By 2011,
only seven confirmed vector-borne autochthonous cases had been described, with four from the
state of Texas, and the remaining three from California, Tennessee, and Louisiana (Bern et al,
2011). In 2014, a cluster of five new autochthonous and likely vector-borne cases was reported
from southeast Texas. Most of the cases were likely infected near their residencies, although two
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may have been infected during recreational outdoor activities (Garcia et al, 2014). Even though
there have not been large numbers of autochthonous case reports of Chagas disease in the United
States, there are likely a very large number of cases going unrecognized and undiagnosed. Much
of the reason for this underdiagnosis is due to the obscure nature of many of the symptoms of
chronic Chagas disease. Many cases of idiopathic heart disease and congestive heart failure in
the United States may in fact be due to chronic Chagas disease, and increasing awareness among
the American physicians community to consider Chagas disease in their differential diagnosis
will be an important public health challenge in upcoming years (Hanford et al, 2007).
Ecological niche modeling examining future habitat suitability for T. cruzi vectors and
reservoirs under climate change predictive models has identified areas of Texas below 30º N
latitude of being at significant risk for local transmission (Sarkar et al, 2010). Other climate
change risk models for Chagas disease predict a widening of current triatomine species
distributions and an increased risk for Chagas disease across the southern and central United
States (Lambert et al, 2008). In any case, it is likely that the number of autochthonous cases in
the United States will continue to go underreported, even if transmission of the parasite expands
and increases in the next years and decades.
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Chapter 2: Study Rationale, Aims, and Research Questions
2.1 Study Rationale and Aims
Stray canines have been implicated as potential reservoirs of both Leishmania and T.
cruzi across South America, Central America, and into Mexico. Numerous details regarding the
enzootic transmission of these pathogens in the southern United States remain either
uninvestigated or unresolved, including the role that domestic dogs may be playing in enzootic
transmission cycles. In Texas, all human cases of cutaneous leishmaniasis have been linked to
the rodent reservoir Neotoma micropus, however, Leishmania has also been identified in
numerous other mammal species (including domestic dogs) in south and central Texas and other
parts of the southern United States. Although no human cases have been reported in west Texas
or the El Paso area, it is acknowledged that phlebotomine and triatomine vectors and competent
reservoirs are likely to inhabit the region but whether they are actively transmitting these
protozoal pathogens is still unknown. Given the behaviors of many stray canines, dogs may have
the potential to move these pathogens from sylvatic cycles in rural or undeveloped areas into
more domestic and peri-urban settings where the potential for transmission to humans is greater.
The discovery of either Leishmania or T. cruzi in stray canines in El Paso County would
represent an emerging public health concern to people living in the region and could be evidence
of novel transmission of these pathogens in the area.
A pilot study conducted by Mariscal in 2013 suggested that enzootic transmission of T.
cruzi and L. mexicana is occurring in the El Paso region. This study examined 96 randomly
selected stray canines from El Paso County and found a 10% overall T. cruzi infection rate. This
same pilot study also found Leishmania present in two stray canines from this sample as well as
in numerous rodent species collected in Mason County, Texas (Mariscal, 2013). It was unclear as
to whether these infection were due to Leishmania mexicana or another Leishmania spp. These
results, however, suggest that there is a significant likelihood of finding further evidence for
transmission of pathogens among stray dogs in the El Paso region.
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The overall aim of this study is to determine whether evidence of Leishmania or T. cruzi
infection can be found among a group of stray dogs collected from across El Paso County,
Texas. PCR-amplification and direct sequencing or PCR-positive amplicons will allow for the
determination of infecting Leishmania species and T. cruzi discrete typing unit among infected
dogs, providing important epidemiologic information on these pathogens in the region that is
currently unknown. Ultimately these results will allow for a better understanding of the enzootic
transmission of Leishmania and T. cruzi in the El Paso area, the Chihuahuan desert, and along
the entire Rio Grande Valley and U.S.-Mexico border. This study may also provide valuable
information as to whether canines in the region have the potential to act as competent reservoirs
for these pathogens and whether there is significant risk posed to people living in urban, periurban, or rural areas of the region.
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2.2 Research Questions
This study is an initial attempt to determine whether enzootic transmission of Leishmania
spp. and Trypanosoma cruzi is occurring among stray canines within El Paso County, Texas. The
frequency of stray dogs infected with either Leishmania or T. cruzi in this sample will be
determined through the PCR-amplification of one Leishmania-specific and two T. cruzi-specific
gene segments and followed by direct sequencing. It is assumed that a relatively low infection
prevalence of L. mexicana among canine skin biopsies will be detected. There is a small
possibility that L. infantum will be detected in spleen biopsies from this group of canines. The
discovery of any other Leishmania spp. is not expected. A very low infection prevalence of L.
mexicana might suggest that dogs are only being incidentally infected with L. mexicana and are
playing a relatively minor role in the overall transmission dynamics of the parasite, however,
further studies will be needed to assess their overall competency as potential reservoirs of this
disease. It is assumed that a higher infection prevalence will be detected in heart or skin biopsies
of these stray canines with respect to T. cruzi relative to Leishmania. This finding would be
consistent with other seroprevalance studies conducted across Texas and throughout the southern
United States. Sequencing of positively identified PCR samples will allow for characterization of
T. cruzi discrete typing unit. Zingales et al. 2012 identified discrete typing unit TcI and TcIV as
being potentially present in sylvatic cycles in the area surrounding El Paso County and it is
possible that either could be identified in this study. Again, further studies in this area will be
necessary to determine whether these canines are only being incidentally infected in this region
or whether they are acting as significant reservoirs in the transmission of T. cruzi.
In addition to the reporting of PCR-positive infection frequencies for these pathogens, all
PCR-positive samples for both Leishmania spp. and for T. cruzi will be mapped based on the
GPS coordinates of where each stray dog was initially found. Mapping of any PCR-positive
samples will allow for an initial determination of whether infection in these dogs is occurring in
a particular region of the county or within a particular ecological setting. These results could
potentially help direct any future studies attempting to study the transmission of these pathogens
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in the region. Furthermore, as canines were sampled regularly for an nearly an entire year, this
study could also assess if there is any temporal pattern of infectivity among these dogs. A cluster
of positive samples (especially if identified in any juvenile canines) being discovered in adjacent
months could indicate that infection is occurring primarily within a particular season and will
elucidate an important temporal aspect of the transmission and epidemiology of these zoonotic
infections.
Direct sequencing of any PCR-positive amplicons for Leishmania or T. cruzi will also
allow for the determination of epidemiologically valuable information on the species of
Leishmania and the discrete typing unit of T. cruzi causing infection in these stray dogs.
Alignment of these sequences with known sequences from reference strains of Leishmania and
T. cruzi will allow for a much more detailed characterization of any infecting protozoa in these
biopsies and can be taken as more definitive evidence of infection.
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Chapter 3: Methods
3.1 Study Design and Stray Canine Tissue Sampling
This study attempted to identify Leishmania spp. and Trypanosoma cruzi among a
sample of stray canines (Canis familiaris) from El Paso County, Texas. All canines in the sample
were captured within El Paso County by trained Animal Control Officers at the City of El Paso
Animal Services. Only animals slated by the City of El Paso Animal Services for euthanasia
were included in this study. No preference was given to dogs of particular age, sex, or breed.
Sample collection was conducted regularly beginning in July 2014 and continued until May
2015. Dogs surrendered by their owners for euthanasia were excluded from study. All euthanasia
of dogs in this study was conducted by a trained animal control officer at the City of El Paso
Animal Services and according to all local and state regulations. Institutional Animal Care and
Use Committee (IACUC) approval was not required, as none of the animals surveyed were
euthanized solely for the purpose of this study but rather were euthanized as part of routine
animal control activities conducted by the City of El Paso Animal Services. IBC approval for this
project was granted by The University of Texas at El Paso Institutional Biosafety Committee
(IRBNet Identification Number: 807121-1).
In all dogs included in the study, information on their approximate age, sex, and breed
was recorded. All dogs over the age of one year were labeled as adults and dogs less than one
year of age had their age estimated in months based on dentition. The breed of each dog was
recorded as it was listed by the Animal Control Officer who initially collected the animal. The
approximate Geographical Positioning System (GPS) coordinates of where each animal was
collected by the City of El Paso Animal Services was also calculated in decimal degrees using
the program GPS Visualizer (http://www.gpsvisualizer.com/geocode).
Biopsies of skin, spleen, and heart tissue were collected from each animal following
euthanasia. Each dog was visually examined for the presence of ulcerative or non-ulcerative skin
lesions prior to skin biopsy collection and if a lesion was identified, the biopsy was collected
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around the afflicted site. Each canine’s spleen and heart was also visually examined for lesions
or discoloration and, if present, biopsies were collected around the afflicted site. Spleen biopsies
were collected around the margin of the organ and heart biopsies were collected at or near the
apex.
Immediately following biopsy collection, tissue samples were stored in a cooler on ice
and were transported to the laboratory for preservation for downstream analysis. To preserve
skin, spleen, and heart tissue samples, each sample was placed in a 10 mL tube and covered with
a DMSO/NaCl/EDTA solution (pH 8.0). This solution contained 20% dimethyl sulfoxide
(DMSO) and 250 mM ethylenediaminetetraacetic acid (EDTA) and was saturated with sodium
chloride (NaCl). Preservation of the tissue samples in this manner allowed for their storage at
room temperature for extended periods of time and without sacrificing the quality or yield of
extracted DNA (Sambrook and Russell, 2001).
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3.2 Data Collection
For each sample, approximately 100 mg of tissue (preserved in DMSO/NaCl/EDTA
solution) was excised from the preserved biopsy sample for genomic DNA extraction. Excised
tissues were placed in a 15 mL tube containing 2 mL SNET (1% w/v sodium dodecyl sulfate;
400 mM NaCl; 5 mM EDTA; 20 mM Tris-Cl) and proteinase K at a concentration of 0.5 mg/mL
(Sambrook and Russell, 2001). Each tube was incubated at 55º C and shaken at approximately
300 rpm overnight in order to break apart the tissue and suspend genomic DNA in the solution.
After overnight incubation, an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1
mixture) was added to each tube. Tubes were then placed on a rocking platform at room
temperature for 30 minutes and centrifuged for 15 minutes at approximately 2600 rpm to
separate aqueous and organic phases. Next, 700 μl of the upper aqueous phase was removed and
placed in a 1.5 mL tube and an equal volume of cold isopropanol was added to the tube and
briefly mixed. Each tube was then centrifuged for 20 minutes at 4 ºC in a tabletop centrifuge at
13,000 rpm to allow for DNA precipitation. The upper layer of isopropanol was removed and the
pellet containing extracted genomic DNA was rinsed with cold 70% ethanol and allowed to dry
for approximately 30 minutes. The pellet was then resuspended by adding 30 μl of nuclease free
water to the tube and briefly vortexed to ensure suspension of genomic DNA. The concentration
of the extracted genomic DNA was determined using a NanoDrop® spectrophotometer.
A working solution of genomic DNA from each tissue sample was made by diluting the
extracted DNA in nuclease free water to a final concentration of approximately100 ng/μl. All
subsequent PCR reactions contained 100 ng of extracted genomic DNA (or parasite DNA for
positive controls), 22 μl 1x PCR Master Mix, and 1 μl of both forward and reverse primers for a
final reaction volume of 25 μl.
Assessment of the quality of extracted genomic DNA from each tissue sample was done
by PCR-amplifying a 227 base pair segment of the mammalian gene encoding interphotoreceptor
retinoid-binding protein (IRBP) (Table3.1). Thermocycler conditions for IRBP amplification
involved an initial denaturation step at 94º C for 4 minutes, followed by 35 cycles at 94º C for 30
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seconds, 57º C for 30 seconds, and 72º C for 1 minute and concluded with a final extension step
at 72º C for 5 minutes (Ferreira et al, 2010) (Table3.2).
Detection of Leishmania spp. was done through the PCR-amplification of a 320 base pair
non-coding segment of Leishmania-specific DNA known as the internal transcribed spacer
(ITS1) and using the primer pair LITSR and L5.8S (Table 3.1). Thermocycler conditions for
ITS1 amplification involved an initial denaturation step at 95º C for 2 minutes, 35 cycles at 95º C
for 20 seconds, 53º C for 30 seconds, and 72º C for 1 minute, and concluded with a final
extension step at 72º C for 6 minutes (El Tai et al, 2000) (Table 3.2).
Trypanosoma cruzi was detected through the amplification of two gene segments, the
first of which was a 188 base pair repetitive nuclear sequence that used the primers Tcz1 and
Tcz2 (Table 3.1). Thermocycler conditions for the amplification of this sequence included an
initial denaturation step of 94º C for 5 minutes, followed by 35 cycles at 94º C for 20 seconds,
57º C for 10 seconds, and 72º C for 30 seconds, and concluded with a final extension step at 72º
C for 7 minutes (Herwaldt et al, 2000; McPhatter et al, 2012) (Table 3.2). The other gene
segment targeting T. cruzi was a 330 base pair segment of kinetoplast minicircle DNA that used
the primers 121 and 122 (Table 3.1). Amplification of this segment included an initial
denaturation step of 94ºC for 3 minutes, followed by 35 cycles at 94ºC for 30 seconds, 57ºC for
30 seconds, and 72ºC for 30 seconds, and concluded with a final elongation step at 72ºC for 7
minutes (Fitzwater et al, 2008) (Table 3.2).
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Table 1: PCR primer pairs and gene segments used for the detection of Leishmania spp. and
Trypanosoma cruzi in stray canine tissue biopsies

Positive controls were run for ITS1, Tcz1/Tcz2, and 121/122 PCRs using genomic DNA
template from Leishmania mexicana (strain M379) and T. cruzi (γ strain). Negative controls in
which no template DNA is included were also run for all ITS1, Tcz1/Tcz2, and 121/122 PCRs.

Table 2: Thermocycler specifications for the amplification of gene segments used for the
detection of Leishmania spp. and Trypanosoma cruzi (*Ferreria et al, 2010; †El Tai
et al, 2000; **McPhatter et al, 2012; ††Fitzwater et al, 2008)
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3.3 Analysis of PCR Results and Sequencing Data
All PCR products were visualized under ultraviolet light on ethidium bromide-stained
agarose gels (containing 1.8% agarose and run in TAE buffer at 100 volts for 20 minutes). Each
gel was made with two combs containing 15 wells each, allowing for the simultaneous analysis
of two canine samples per gel. Gels for each canine sample contained a well with 100 bp or 1 kb
DNA ladder (New England Biolabs®) in order to estimate the size in base pairs of any DNA
fragments obtained through PCR. Gels for each canine sample also contained IRBP, ITS1, and
Tcz1/Tcz2 PCR products for each spleen, heart, and skin biopsy from the given canine. Positive
and negative controls were also included from both the ITS1 and Tcz1/Tcz2 PCR. 121/122 PCR
products were run on separate gels including the corresponding positive and negative controls.
Each canine’s skin, spleen, or heart samples were considered PCR-positive if a DNA fragment is
visually observed with the same approximate size and migration pattern as that of the respective
positive control.
The frequencies of PCR-positive biopsies and PCR-positivity percentages were
calculated. Positive samples were also examined according to canine sex, age, breed group, and
lesion status in order to make a preliminary determination of potential trends among infected
dogs. The date in which any positive sample is identified was also examined in an attempt to
determine whether dogs are being infected during a particular time of year. Finally, PCR-positive
samples were mapped based on the GPS coordinates of where each dog was initially collected in
order to determine whether any spatial or ecological pattern exists with respect to any PCRpositive samples. Maps were created using the computer program Epi Info™ (Version 7.1.4)
developed by the U.S. Centers for Disease Control and Prevention.
Samples identified as PCR-positive after visualization through agarose gels
electrophoresis were randomly selected for bidirectional sequencing. Sequencing services were
provided by the Genomic Analysis Core Facility at the Department of Biological Sciences at The
University of Texas at El Paso. Sequenced PCR products were analyzed using the Basic Local
Alignment Search Tool (BLAST®) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the program
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MView (http://www.ebi.ac.uk/Tools/msa/mview/) was used to create a multiple sequence
alignment comparing sequenced PCR products.
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Chapter 4: Results
4.1 Stray Canine Sample Description
Tissue biopsies were collected from stray canines at City of El Paso Animal Services
between July 2, 2014 and May 27, 2015. During this period, biopsies were collected on 33
separate days with approximately five canines being sampled on each collection date. In total,
skin, spleen, and heart biopsies from 159 stray dogs were obtained. Data from all dogs were
recorded into a spreadsheet, and dogs were cataloged according to the order in which their
biopsies were taken. For convenience, all dogs surveyed were given the moniker “K” followed
by a number, with the first dog surveyed being cataloged as “K1”, the second dog as “K2”, and
so forth for all 159 dogs for which tissues were collected.
A nearly even distribution of male and female dogs was found with 81 being female and
78 being male, representing 50.9% and 49.1% of the sample, respectively (Table 3). Based on
dentition patterns, the majority of dogs in the sample were classified as adults (i.e., greater than
one year of age) with only 14.5% of dogs in the sample being less than one year of age. An age
range of 2 months to 10 months was found among the 23 dogs in the group considered to be less
than one year of age. Skin lesions were noted on 41 of the dogs surveyed with lesions being
distributed across the animals’ bodies and often on more exposed areas. Biopsies of both
ulcerative and non-ulcerative lesions were collected if present. Lesions, discoloration or other
abnormalities of the spleen were noted in 43 dogs and visible lesions of the myocardium were
noted in 30 dogs (Table 3).
Each stray dog was also categorized into one of seven different breed groups based on the
standards of the American Kennel Club (AKC), a determination that was made based solely on
each animal’s external appearance or by the breed noted by the Animal Control Officer that
initially collected it. Any dog that was clearly of mixed breed was included in the breed group
that was considered most dominant based on external appearance. In all, 31 dogs, representing
19.5% of the sample, were included in the Herding group, which included the breeds of German
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shepherd, Australian shepherd, and border collie, among others. Two dogs were included in the
Hound group, both of which were recorded as beagles. A total of 17 dogs were included in the
Non-sporting group, the majority of which were poodles. 11 dogs were included in the Sporting
group, which included the breeds Labrador retriever, cocker spaniel, and golden retriever. The
largest breed group in the sample was the Terrier group, which included 57 dogs and represented
35.8% of the sample. Breeds included in the Terrier group included pit-bull terriers and Russell
terriers, among other terrier mixes. 33 dogs were included in the Toy group, representing 20.8%
of the sample, the majority of which were considered Chihuahuas or Chihuahua mixes. Finally, 8
dogs were included in the Working group, which represented 5.0% of the sample and included
the breeds St. Bernard, boxer, and husky (Table 3).

Table 3: El Paso County stray canine sample characteristics (*Age was estimated based on
dentition characteristics; †American Kennel Club breed group determination made
based on external appearance)
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Stray canines were collected from across El Paso County with the large majority coming
from suburban, peri-urban, and agricultural areas from the western portion of the county near the
city of El Paso and its surrounding communities. The GPS coordinates at which each stray dog
was captured were recorded, and a map of all 159 capture locations was created using Epi Info™
7.1.4 (Figure 7). Clusters of capture locations with large numbers of stray canines are visible in
the northeastern portion of the city of El Paso and along the agricultural regions to the southeast
of El Paso and following the Rio Grande. Fewer dogs comparatively came from the area west of
the Franklin Mountains and from urban, more densely populated areas of the city.

Figure 7: Distribution of stray canine capture locations across El Paso County (Map prepared
with Epi Info™ 7.1.4)
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4.2 PCR Detection of Leishmania spp. and Trypanosoma cruzi
PCR amplification of the IRBP segment was positive for the majority of skin, spleen and
heart biopsies when viewed under agarose gel electrophoresis and indicated that preceding
extraction of genomic DNA from tissue biopsies was largely successful. IRBP amplification of
skin, spleen, or heart biopsies was only unsuccessful in three of the 159 stray dogs. These three
samples were excluded from subsequent analyses and a final sample size of 156 was thus used
for all remaining frequency calculations.
Agarose gel electrophoresis was conducted for all samples with each gel including one
canine’s skin, spleen, and heart biopsy PCR products for the gene segments IRBP, ITS 1 and
Tcz. In addition to PCR products for each sample, positive and negative controls were also
included for ITS 1 and Tcz as well as a DNA ladder with fragments of known sizes. A
representative example of an agarose gel that was considered negative for both Leishmania (ITS
1) and T. cruzi (Tcz) is shown in Figure 8.
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Figure 8: Representative agarose gel with negative results for both ITS 1 and Tcz PCRs (K59
represents the canine sample catalog number) (SP: Spleen; H: Heart; SK: Skin; + C:
Positive Control; - C: Negative Control)

Of the 156 stray dogs for which IRBP amplification was successful, the ITS 1 region was
amplified in 41, representing 26.3% of the total sample. Samples were considered positive if a
clear fragment was observed that resembled the positive control in both size (320 bp) and
migration pattern. Positive samples were identified in spleen, heart and skin biopsies, with skin
and spleen biopsies being those that had the largest proportion of PCR-positive fragments. Figure
9 shows an agarose gel that was PCR-positive in the ITS 1 region in all three biopsy tissue types.
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Figure 9: Agarose gel with positive results for Leishmania spp. in skin, spleen, and heart biopsy
PCRs (PCR-positive biopsies indicated in red) (SP: Spleen; H: Heart; SK: Skin; +
C: Positive Control; - C: Negative Control)

Amplification of 121/122 and Tcz gene segments was successful in a total of 21 stray
canines for a final PCR-positivity frequency of 13.5%. Kinetoplast minicircle DNA from T. cruzi
using the 121/122 primers was detected in heart biopsies from seven canine samples (Agarose
gel not shown). Amplification of Tcz was primarily successful using genomic DNA from heart
biopsies but was also detected in a smaller number of spleen biopsies. Figure 10 shows an
agarose gel that was negative for the ITS 1 region but positive for the Tcz gene segment with a
visible fragment of the expected size (188 bp) seen in the heart biopsy PCR product.
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Figure 10: Agarose gel with positive result for Trypanosoma cruzi in heart biopsy PCR (PCRpositive biopsy indicated in red) (SP: Spleen; H: Heart; SK: Skin; + C: Positive
Control; - C: Negative Control)

The demographic characteristics of the 41 stray canines that were found to be positive for
Leishmania spp. closely resembled those of the overall sample. No clear sex difference existed
among the positive samples with 53.7% being male dogs and 46.3% being female (Table 4).
29.3% of positive samples were taken from stray dogs that showed visible skin lesions at the
time of biopsy collection, which was slightly higher than the 25.6% skin lesion prevalence in the
total sample (Table 4). The prevalence of spleen lesions or abnormalities in the positive samples
was also slightly higher than that of the overall sample with 29.3% of dogs showing evidence of
such lesions in the positive group compared to 26.3% in the overall sample (Table 4). Positive
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samples did not appear to cluster within dogs of a particular breed group, with the distribution in
Leishmania spp. PCR-positive dogs closely resembling that of the overall sample (Table 4.) Of
the 41 dogs testing positive for Leishmania spp., 28 (68%) were taken from dogs captured during
the late summer and early fall months, from July to September 2014. Most of the remaining
samples were detected in the winter months from November 2014 to February 2015.

Table 4: Comparison of demographic characteristics between stray canines identified as PCRpositive for Leishmania spp. and the overall sample tested

Dogs that tested positive for Leishmania spp. were distributed across El Paso County.
The majority of positive samples were found in the western and northeast portions of the city of
El Paso and along the Rio Grande in agricultural areas to the southeast of the city (Figure 11). Of
note is that of the few stray canines that were captured west of the Franklin Mountains, about
half tested positive for Leishmania, indicating that this may be a potential area of greater
transmission.
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Figure 11: Geographic distribution of stray canines identified as PCR-positive and PCR-negative
for Leishmania spp. (Map prepared with Epi Info™ 7.1.4)

Demographic characteristics of the 21 stray canine samples found to be PCR-positive for
T.cruzi largely resembled those of the overall sample with some notable exceptions. No clear sex
difference existed in the positive sample with 52.4% of positive dogs being female as compared
to 50.6% of the overall sample (Table 5). No clear difference was also seen between the positive
group and overall sample with respect to age with 14.3% of the positive dogs and 14.7% of the
overall sample being less than one year of age (Table 5). An interesting difference was noted
with respect to the proportion of myocardial lesions between the dogs with evidence of T. cruzi
infection and the overall sample. In 42.9% of dogs testing positive for T. cruzi, visible lesions of
the myocardium were observed, while only 17.9% of dogs in the overall sample showed such
lesions (Table 5). In terms of breed groups, no obvious differences were observed between the
positive group and overall sample, however there were slightly more dogs considered to be in the
Terrier group and slightly fewer in the Toy group in the positive sample as compared to the
overall sample (Table 5). The majority of PCR-positive T. cruzi samples were detected in stray
46

canines captured during the winter months between November 2014 and February 2015. 15 stray
canines, representing 71% of the positive sample, were captured during these months.

Table 5: Comparison of demographic characteristics between stray canines identified as PCRpositive for Trypanosoma cruzi and the overall sample tested

The distribution of stray dogs found to be PCR-positive for T. cruzi also indicated that
positive dogs were captured in areas throughout El Paso County and were not isolated to a
particular region or locale within the county. A small cluster of six positive cases was observed
in the northeast portion of the city of El Paso that can be seen in Figure 12. The remaining cases
were distributed in the western and eastern portions of the city of El Paso and in the region along
the Rio Grande to the city’s southeast (Figure 12).
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Figure 12: Geographic distribution of stray canines identified as PCR-positive and PCR-negative
for Trypanosoma cruzi (Map prepared with Epi Info™ 7.1.4)
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4.3 Sequencing Results
Of the 41 samples determined to be PCR-positive for Leishmania spp. following
amplification of the ITS 1 region, 18 were randomly chosen for sequencing. BLAST® analysis of
sequences from these samples indicated that all 18 clearly fit into the Leishmania mexicana clade
with a large degree of sequence homology to the sequences of known L. mexicana reference
strains. A multiple sequence alignment was created using the program MView in which the
amount of ITS 1 sequence homology to one reference strain of L. mexicana (M379) can be seen
(Figure 13). The ITS 1 sequence of L. major (Friedlin strain) was included as an outgroup to
highlight sequence differences between these distantly related Leishmania species.

Figure 13: Abbreviated multiple sequence alignment showing L. mexicana (M379) reference
strain (Row 1) and 18 samples identified as PCR-positive for Leishmania spp. (L.
major Friedlin strain included as outgroup in Row 20)

Amplification of T. cruzi PCR products was attempted in six tissue biopsies that tested
positive for the Tcz primer pair and in three biopsies that tested positive for the 121/122 primer
pair. The sequenced PCR products that were obtained from these biopsies as well as those from
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the T. cruzi γ strain control could not confirm the presence of T. cruzi. BLAST® analysis of all
sequenced PCR products, including controls, was inconclusive and thus multiple sequence
alignments were not created for these samples.
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Chapter 5: Discussion
The results from this study suggest that transmission of both L. mexicana and T. cruzi is
occurring across a widespread portion of El Paso County and in areas with significant human
populations (i.e., the city of El Paso). This study found that a relatively large proportion of stray
dogs in El Paso County show evidence of infection with L. mexicana and T. cruzi. More research
will be needed to determine whether this represents a new emergence of these parasites and to
fully assess the degree of risk for autochthonous transmission to people in the region.
This study found evidence of Leishmania infection in 41 dogs out of an overall sample of
156, for an overall positivity frequency of 26.3%. No major differences were found with respect
to the sex, age, or breed group of dog infected, indicating that these variables are likely not major
factors influencing a dog’s susceptibility to Leishmania. Slightly more dogs that were positive
for Leishmania spp. were found to have skin lesions as compared to the overall group, indicating
that some dogs may be developing cutaneous lesions in response to infection. However,
numerous PCR-positive dogs were found that lacked any cutaneous lesions, suggesting that
lesion development is not a universal sign of infection. The largest cluster of PCR-positive
canines was detected within the late summer and early fall months, between July and September.
Taking into account incubation times before Leishmania parasites are detectable in tissue, this
finding indicates that transmission to canines is likely occurring during the middle of the summer
and into the early fall months. Interestingly, of the six PCR-positive dogs that were less than one
year of age, five were detected during these few months, giving further support to the idea that
peak transmission is likely occurring during this period. Furthermore, infections with Leishmania
detected during this period were often found in all three tissue types (i.e., skin, spleen, and heart),
a finding that indicates wide circulation of parasites through the circulatory system at the time of
detection. There was no clear spatial pattern among infected dogs, as positive dogs were found
throughout El Paso County. Positive cases can be seen in the northeast and far east portions of El
Paso and along the Rio Grande east of the city. A possible cluster of positive cases is also
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evident to the west of the Franklin Mountains where about half of all canines screened were
infected suggesting that this area may be a focus of transmission.
Sequencing analysis from the 18 PCR-positive stray canines samples indicated that all
infections were clearly caused by Leishmania mexicana with no other Leishmania spp. being
detected. There was a remote possibility that L. infantum would be found in this group, as it has
been reported in hunting dogs in parts of the eastern United States and Oklahoma, however this
study found no evidence of its presence in the El Paso area.
The proportion of positive samples found in this study is markedly higher than that found
by Mariscal in 2013 (2%) that also surveyed stray canines in El Paso County. There are
numerous possible reasons for this discrepancy with a major reason being the primers used for
PCR analysis. It is possible that the ITS 1 gene segment that was amplified in this study to detect
Leishmania spp. has a greater sensitivity and is able to detect parasites in tissues at significantly
lower levels. Another possible reason for this discrepancy is climatic. The summer, fall, and
winter of 2014 and spring of 2015 had noticeably more precipitation and also had significantly
warmer temperatures that previous years. Both these environmental factors could favor
phlebotomine vector proliferation and lead to a greater number of canine infections.
Interestingly, the Mariscal study in 2013 also found a temporal pattern to infectivity similar to
that found in this study, with the majority of Leishmania infections being reported in the later
summer and early fall months.
This study also found evidence of T. cruzi infection in 21 dogs out of the overall sample
of 156, for a positivity frequency of 13.5%. As with Leishmania, no obvious differences were
found with respect to sex, age, or breed group between the PCR-positive and PCR-negative stray
canines. Stray canines testing positive for T. cruzi, however, were much more likely to have
visible lesions of the myocardium when compared to the overall sample, with 42.9% of positive
dogs having myocardial lesions compared to only 17.9% in the total sample. This finding and the
fact that the majority of T. cruzi infections were found from heart biopsies is understandable
given the pathobiology of the T. cruzi parasite and its proclivity to infect heart muscle. The
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largest cluster of PCR-positive stray canines for T. cruzi was found between the months of
November and February, indicating that this period might be a time during which increased
transmission is occurring. However due to the chronic nature of many T. cruzi infections and the
ability of the parasite to reside in tissue for many years, it is also possible that this apparent
cluster of cases during these months does not reflect a time of greater transmission. No apparent
spatial pattern to T. cruzi PCR-positive stray canines was found, suggesting that transmission of
T. cruzi is occurring throughout El Paso County.
Sequencing of T. cruzi PCR products for the Tcz and 121/122 gene segments was
inconclusive and unable to confirm the findings from PCR analyses. This precluded
determination of discrete typing unit in any samples identified as PCR-positive. Despite the
failure to confirm the presence of T. cruzi through sequencing, the samples determined to be
PCR-positive were most likely infected with T. cruzi, but in levels that were low enough as to
not provide an adequate amount of PCR product for sequencing. It is unlikely that DNA from
other protozoal parasites was being amplified in these tissue biopsies. Attempts to amplify
Leishmania DNA using either Tcz1/Tcz2 or 121/122 primer pairs did not lead to the
visualization of any PCR product, making it unlikely that the results obtained were the result of
any crossreactivity.
The results from the Mariscal 2013 study found a similar proportion of canines infected
with T. cruzi (10%) as were found in this study (13.5%). The two studies also identified the late
fall and winter months as those in which most positive canines were found, giving further
support to the idea that this may be a time when greater transmission is occurring. Both studies
also did not find a clear spatial pattern among positive samples and support the assumption that
transmission is occurring over a widespread portion of El Paso County.
Overall, this study provides strong evidence that transmission of both L. mexicana and T.
cruzi is occurring over a widespread portion of El Paso County. One major question that remains
to be answered about the transmission of these pathogens concerns the biology of their respective
vectors in the region. L. mexicana is potentially being transmitted to stray dogs by the sand fly
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vectors Lutzomyia anthophora and Lutzomyia diabolica. These two vector species have been
found throughout central and south Texas, where they have been linked to enzootic and zoonotic
transmission of L. mexicana, but no study to date has identified either vector in the El Paso
region. Similarly, it is unclear how dogs are being infected with T. cruzi. The triatomine vector
species Triatoma rubida, Triatoma protracta, Triatoma sanguisuga, Triatoma indictiva, and
Triatoma gerstaeckeri have all been collected from areas of west and south Texas with an
ecology roughly similar to that of El Paso, and it is likely that some combination of these vector
species are inhabiting the El Paso area. The question of which triatomine species are present in
the area and how they may be infecting stray canines still remains to be answered. It is possible
that canines, rather than being physically bitten by infected triatomines, are acquiring their
infections by ingesting whole triatomine bugs. Further research will be needed to determine
which route of infection is more likely to be occurring.
Another important concern that remains to be studied is the estimated risk that these
pathogens pose to people living in the El Paso region. Small numbers of autochthonous cases of
both cutaneous leishmaniasis caused by L. mexicana and Chagas disease have been reported
from central, south, and north Texas. The presence of these pathogens in stray canines from El
Paso County suggests that there is at least some potential for autochthonous human infection.
People living in rural and agricultural areas of the county are likely to be at greatest risk for
infection and increased efforts on behalf of the the public health community of El Paso are
needed to increase awareness of these parasites and to provide efficacious methods to prevent
potential infection. The data and results from this study will hopefully be used in conjunction
with other studies that examine the presence of these parasites over extended periods of time,
ultimately leading to a more comprehensive understanding of their epidemiology and the risk
they pose to people. The results from this study may also be valuable in future years in order to
assess whether transmission of these pathogens is increasing in response to global climate
change.
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Chapter 6: Conclusion
Collectively, the results from this study add to the understanding that enzootic
transmission of L. mexicana and T. cruzi is occurring across a large portion of the southern
United States and in areas where these pathogens were recently not believed to have been
present. The relatively high proportion of stray canines with evidence of L. mexicana and T.
cruzi infection found in this study suggest that transmission of these two parasites is occurring
frequently and likely is infecting other domestic and sylvatic mammals in the region. Increased
awareness of the presence of these pathogens in the El Paso area is greatly needed, especially
among physicians, veterinarians, and those working in public health. Physicians in El Paso and
across the southern United States should begin to consider cutaneous leishmaniasis and Chagas
disease in their differential diagnoses in cases of idiopathic cutaneous lesions or
cardiomyopathies, respectively. More research is needed in order to better understand the
complex transmission dynamics of these pathogens between sylvatic and domestic reservoirs and
their respective vectors.
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